Stock Information
Biontech SE (BNTX)
Ticker Symbol: BNTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $24,236.43 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -6.71
Revenue (TTM): $10.46 M
Dividend Yield: N/A
ROE: -9.1%
Latest News
-
Syndax Pharmaceuticals, BioNTech, Seagate And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Tue, Oct 13, 2026 8:02 AM
-
BioNTech Reports AHEAD-MERIT Phase 2/3 Clinical Trial Did Not Meet First Dual Primary Endpoint Of Progression-Free Survival For mRNA Cancer Immunotherapy Candidate BNT113 Plus Pembrolizumab Compared With Pembrolizumab Alone
Tue, Oct 13, 2026 6:47 AM
-
Vaccine Stocks Rally on Reports of U.S.-led Push for Cancer Vaccines
Mon, Oct 12, 2026 2:12 PM
-
Why Did BioNTech (BNTX) Move Today?
Sat, Oct 10, 2026 5:10 PM
-
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
Fri, Oct 9, 2026 3:48 PM
-
A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally
Fri, Oct 9, 2026 3:11 PM
-
Reported Earlier: 'Cancer Vaccines Are the N.I.H's Next Big Bet' - The New York Times
Fri, Oct 9, 2026 11:00 AM
-
Is BioNTech (NasdaqGS:BNTX) Overvalued As Sales Face A Reset?
Wed, Oct 7, 2026 9:12 PM
-
Morgan Stanley Maintains Overweight on BioNTech, Lowers Price Target to $114
Wed, Oct 7, 2026 10:23 AM
-
Moderna Is Up 545% in 2026: Take Profits Now, or Keep Buying?
Tue, Oct 6, 2026 7:03 PM
Key Financials
Financial data not available